AI Insight
A new study from the Buck Institute for Research on Aging, published in Aging Cell, investigates why carriers of the APOE2 gene variant tend to live longer and show partial protection against Alzheimer's disease. The research provides a mechanistic explanation: APOE2 enhances the ability of human neurons to repair DNA damage and resist cellular senescence, a state in which cells become dysfunctional and cease to divide normally. This accumulation of senescent cells is a known contributor to neurodegeneration and age-related cognitive decline.
Why it matters
Understanding the protective mechanism of APOE2 at the cellular level could open new therapeutic avenues targeting DNA repair pathways or senescence in neurons, potentially informing treatments for Alzheimer's disease and other age-related neurodegenerative conditions.
People who carry the APOE2 version of the apolipoprotein E gene are more likely to live to advanced age and are partly protected against Alzheimer’s disease, but scientists have struggled to explain why. A new study from the Buck Institute for Research on Aging, now published in Aging Cell, offers a mechanistic answer: APOE2 helps human neurons keep their DNA intact and resist becoming senescent, a damaged, dysfunctional state that accumulates with age and contributes to neurodegeneration.
Source: Longevity-linked APOE2 gene variant helps neurons repair DNA and resist aging